Ashland ASH Business Segments
| TTM Q2 '26 | TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | ||
|---|---|---|---|---|---|---|
| Revenue by Business | ||||||
| Intermediates And Solvents | $132M-7.0% | $134M-7.6% | $136M-6.2% | $139M-4.8% | $142M-7.2% | |
| Life Sciences | $646M-6.9% | $646M-13.2% | $641M-20.9% | $661M-19.4% | $694M-17.8% | |
| Personal Care And Household | $571M-7.3% | $567M-11.3% | $578M-8.8% | $588M-5.0% | $616M+4.4% | |
| Specialty Additives | $498M-8.1% | $498M-11.9% | $511M-10.7% | $523M-8.7% | $542M-5.7% | |
| Operating Income by Business | ||||||
| Intermediates And Solvents | $10M-33.3% | $5M-80.0% | $8M-72.4% | $13M-40.9% | $15M-48.3% | |
| Personal Care And Household | $89M+6.0% | $90M+11.1% | $90M+25.0% | $78M+8.3% | $84M+52.7% | |
| Specialty Additives | -$360M— | -$346M— | -$343M— | —— | —— | |
| Unallocated And Other | -$106M+73.8% | -$97M+77.9% | -$273M-3.4% | -$303M-13.9% | -$405M-202% | |
| Earnings Before Interest Tax Depreciation And Amortization by Business | ||||||
| Intermediates And Solvents | $18M-33.3% | $15M-59.5% | $20M-51.2% | $25M-26.5% | $27M-34.1% | |
| Personal Care And Household | $150M-4.5% | $151M-5.0% | $154M+1.3% | $146M-5.2% | $157M+13.8% | |
| Specialty Additives | -$291M-420% | -$276M-394% | -$275M-409% | -$251M-449% | $91M+42.2% | |
| Unallocated And Other | -$106M+73.8% | -$97M+77.9% | -$273M-3.4% | -$303M-13.9% | -$405M-202% | |
| Total Assets by Business | ||||||
| Intermediates And Solvents | $451M-8.7% | $463M-9.2% | $477M-7.9% | $488M-7.4% | $494M— | |
| Life Sciences | $5.95B-17.9% | $6.37B-12.6% | $6.72B-8.9% | $7B-6.7% | $7.24B-5.5% | |
| Personal Care And Household | $2.89B-13.5% | $2.88B-20.6% | $2.87B-26.2% | $3.07B-22.2% | $3.34B— | |
| Specialty Additives | $4.05B-28.9% | $4.41B-24.8% | $4.75B-22.2% | $5.24B-14.9% | $5.69B-9.7% | |
| Unallocated And Other | $4.92B-3.3% | $4.87B-8.1% | $4.88B-8.4% | $4.93B-8.2% | $5.09B-2.8% | |
| Adjustment For Amortization by Business | ||||||
| Intermediates And Solvents | $1M+200% | $1M+200% | $1M+200% | -$1M0.0% | -$1M0.0% | |
| Life Sciences | $20M0.0% | $19M-9.5% | $19M-17.4% | $19M-26.9% | $20M-25.9% | |
| Personal Care And Household | $33M-15.4% | $33M-21.4% | $35M-18.6% | $37M-15.9% | $39M-15.2% | |
| Specialty Additives | $8M-20.0% | $9M-18.2% | $9M-25.0% | $9M-35.7% | $10M-37.5% | |
| Depreciation by Business | ||||||
| Intermediates And Solvents | $8M-38.5% | $10M-23.1% | $12M-7.7% | $13M0.0% | $13M0.0% | |
| Life Sciences | $44M-10.2% | $57M+50.0% | $57M+50.0% | $57M+46.2% | $49M+19.5% | |
| Personal Care And Household | $28M-17.6% | $28M-22.2% | $29M-21.6% | $31M-18.4% | $34M-8.1% | |
| Specialty Additives | $78M+27.9% | $78M-11.4% | $76M-30.3% | $75M-31.8% | $61M-41.9% | |
| Goodwill by Business | ||||||
| Life Sciences | $1.86B-42.3% | $2.21B-32.1% | $2.53B-23.2% | $2.89B-12.4% | $3.23B-2.8% | |
| Specialty Additives | $449M-73.6% | $763M-55.1% | $1.07B-37.8% | $1.39B-18.4% | $1.7B-0.4% | |
| Goodwill Impaired Accumulated Impairment Loss by Business | ||||||
| Life Sciences | $1.5B— | —— | —— | —— | —— | |
| Specialty Additives | $2.02B+190% | $1.69B+143% | $1.36B+95.1% | $1.03B+47.6% | $696M0.0% | |
| Revenue by Geography | ||||||
| Asia Pacific | $478M-6.3% | $473M-9.7% | $477M-8.8% | $491M-1.4% | $510M+3.2% | |
| Europe | $659M-4.2% | $661M-7.7% | $663M-9.9% | $672M-9.2% | $688M-6.8% | |
| Latin America And Other | $189M+2.7% | $186M-3.1% | $187M-3.1% | $182M-7.6% | $184M-10.2% | |
| North America | $521M-14.9% | $525M-20.6% | $539M-24.0% | $566M-21.7% | $612M-15.6% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How does Ashland break its business down?
- Ashland (ASH) reports revenue by business across 4 parts — Intermediates And Solvents, Life Sciences, Personal Care And Household and Specialty Additives. Each is extracted from the segment footnotes and tracked over time.
- Where does Ashland's segment data come from?
- Segment breakdowns are pulled from the segment footnotes in Ashland's SEC filings (the XBRL dimensional tags), so every line ties back to a reported figure. Switch between quarterly, annual, and TTM, or open any segment for its full history.
